We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,104 hedge funds and large institutions have $68.4B invested in Allergan plc in 2017 Q1 according to their latest regulatory filings, with 135 funds opening new positions, 401 increasing their positions, 453 reducing their positions, and 105 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 135 | Existing positions closed: 105

7% more capital invested

Capital invested by funds: $64B → $68.4B (+$4.41B)

1% more funds holding

Funds holding: 1,0911,104 (+13)

11% less repeat investments, than reductions

Existing positions increased: 401 | Existing positions reduced: 453

13% less funds holding in top 10

Funds holding in top 10: 8977 (-12)

22% less call options, than puts

Call options by funds: $2.64B | Put options by funds: $3.38B

Holders
1,104
Holders Change
+13
Holders Change %
+1.19%
% of All Funds
27.48%
Holding in Top 10
77
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-13.48%
% of All Funds
1.92%
New
135
Increased
401
Reduced
453
Closed
105
Calls
$2.64B
Puts
$3.38B
Net Calls
-$733M
Net Calls Change
-$1.05B
Name Holding Trade Value Shares
Change
Change in
Stake
NSB
1101
Norway Savings Bank
Maine
$1K
RI
1102
Redwood Investments
Massachusetts
$1K
NYLT
1103
New York Life Trust
New York
$1K +$932 +4 New
WOC
1104
West Oak Capital
California
$717
EM
1105
Elliott Management
New York
-$574M -2,735,000 Closed
OAG
1106
Orbis Allan Gray
Bermuda
-$150M -714,633 Closed
HT
1107
HAP Trading
New York
-$140M -600,859 Closed
IC
1108
Icahn Carl
Florida
-$89.3M -425,438 Closed
DLPIC
1109
Davide Leone & Partners Investment Company
United Kingdom
-$53.4M -254,193 Closed
AC
1110
Alleghany Corporation
New York
-$50.4M -240,000 Closed
TBC
1111
Three Bays Capital
Massachusetts
-$44.6M -212,297 Closed
BTP
1112
Bloom Tree Partners
New York
-$40.6M -193,199 Closed
CFIC
1113
City Financial Investment Company
United Kingdom
-$37.8M -180,000 Closed
BWCA
1114
Brenner West Capital Advisors
New York
-$36.2M -172,229 Closed
CC
1115
Coastland Capital
California
-$34.9M -166,250 Closed
SAM
1116
Senzar Asset Management
New York
-$33.3M -158,700 Closed
ZDA
1117
Zweig-DiMenna Associates
New York
-$29.8M -141,890 Closed
BCPEM
1118
Bain Capital Public Equity Management
Massachusetts
-$29.1M -138,508 Closed
Marshall Wace
1119
Marshall Wace
United Kingdom
-$28.6M -135,999 Closed
Nomura Holdings
1120
Nomura Holdings
Japan
-$24.4M -116,287 Closed
NTC
1121
North Tide Capital
Massachusetts
-$21M -100,000 Closed
WI
1122
Wafra Inc
New York
-$18.5M -87,922 Closed
QIM
1123
Quest Investment Management
Oregon
-$17.7M -84,154 Closed
SFM
1124
Soros Fund Management
New York
-$16.2M -77,135 Closed
CC
1125
Clearline Capital
New York
-$13.4M -63,699 Closed

AGN Hedge Fund Activity: Q1 2017 in Review

1,104 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2017, worth a combined $68.4B — up 6.9% from $64B a quarter earlier.

Buyers outnumbered sellers: 135 funds opened new AGN positions and 105 closed out — a net gain of 30 holders — while 401 added to existing stakes and 453 trimmed.

The largest buyer was BlackRock, adding an estimated $4.61B. The largest seller was Elliott Management, exiting entirely with an estimated $574M sold.

  • 1,104 institutional investors held Allergan plc (AGN) as of Q1 2017, up from 1,091 in Q4 2016.
  • Funds reported $68.4B of Allergan plc stock for Q1 2017, up 6.9% quarter-over-quarter.
  • 135 funds opened new Allergan plc positions in Q1 2017 and 105 closed out, a net change of +30 holders.
  • The largest Allergan plc buyer in Q1 2017 was BlackRock, an estimated $4.61B added.
  • The largest Allergan plc seller in Q1 2017 was Elliott Management, an estimated $574M sold.

Based on aggregated 13F filings for Q1 2017.